BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 28780718)

  • 1. Clinical and radiographic comparison of biodentine, mineral trioxide aggregate and formocresol as pulpotomy agents in primary molars.
    Juneja P; Kulkarni S
    Eur Arch Paediatr Dent; 2017 Aug; 18(4):271-278. PubMed ID: 28780718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report.
    Eidelman E; Holan G; Fuks AB
    Pediatr Dent; 2001; 23(1):15-8. PubMed ID: 11242724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars.
    Noorollahian H
    Br Dent J; 2008 Jun; 204(11):E20. PubMed ID: 18425074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial.
    Cuadros-Fernández C; Lorente Rodríguez AI; Sáez-Martínez S; García-Binimelis J; About I; Mercadé M
    Clin Oral Investig; 2016 Sep; 20(7):1639-45. PubMed ID: 26578117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth.
    Moretti AB; Sakai VT; Oliveira TM; Fornetti AP; Santos CF; Machado MA; Abdo RC
    Int Endod J; 2008 Jul; 41(7):547-55. PubMed ID: 18479381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2-year follow-up.
    Ansari G; Ranjpour M
    Int Endod J; 2010 May; 43(5):413-8. PubMed ID: 20518934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of a novel alternative to conventional formocresol-zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser-mineral trioxide aggregate pulpotomy.
    Saltzman B; Sigal M; Clokie C; Rukavina J; Titley K; Kulkarni GV
    Int J Paediatr Dent; 2005 Nov; 15(6):437-47. PubMed ID: 16238654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Radiographic Evaluation of the Effectiveness of Formocresol, Mineral Trioxide Aggregate, Portland Cement, and Enamel Matrix Derivative in Primary Teeth Pulpotomies: A Two Year Follow-Up.
    Yildirim C; Basak F; Akgun OM; Polat GG; Altun C
    J Clin Pediatr Dent; 2016; 40(1):14-20. PubMed ID: 26696101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of formocresol and mineral trioxide aggregate in pulpotomized primary molars--2 year follow up.
    Airen P; Shigli A; Airen B
    J Clin Pediatr Dent; 2012; 37(2):143-7. PubMed ID: 23534319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulp treatment for extensive decay in primary teeth.
    Smaïl-Faugeron V; Glenny AM; Courson F; Durieux P; Muller-Bolla M; Fron Chabouis H
    Cochrane Database Syst Rev; 2018 May; 5(5):CD003220. PubMed ID: 29852056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24-month study.
    Erdem AP; Guven Y; Balli B; Ilhan B; Sepet E; Ulukapi I; Aktoren O
    Pediatr Dent; 2011; 33(2):165-70. PubMed ID: 21703067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mineral trioxide aggregate and formocresol pulpotomy on vital primary teeth: a clinical and radiographic study.
    Olatosi OO; Sote EO; Orenuga OO
    Niger J Clin Pract; 2015; 18(2):292-6. PubMed ID: 25666010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth.
    Agamy HA; Bakry NS; Mounir MM; Avery DR
    Pediatr Dent; 2004; 26(4):302-9. PubMed ID: 15344622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of formocresol and mineral trioxide aggregate as pulpotomy agents in deciduous teeth.
    Srinivasan D; Jayanthi M
    Indian J Dent Res; 2011; 22(3):385-90. PubMed ID: 22048576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol.
    Holan G; Eidelman E; Fuks AB
    Pediatr Dent; 2005; 27(2):129-36. PubMed ID: 15926290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and comparison of mineral trioxide aggregate and biodentine in primary tooth pulpotomy: Clinical and radiographic study.
    Carti O; Oznurhan F
    Niger J Clin Pract; 2017 Dec; 20(12):1604-1609. PubMed ID: 29378994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and radiographic success of mineral trioxide aggregate compared with formocresol as a pulpotomy treatment in primary molars: a systematic review and meta-analysis.
    Marghalani AA; Omar S; Chen JW
    J Am Dent Assoc; 2014 Jul; 145(7):714-21. PubMed ID: 24982277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and radiographic comparison of platelet-rich fibrin and mineral trioxide aggregate as pulpotomy agents in primary molars.
    Patidar S; Kalra N; Khatri A; Tyagi R
    J Indian Soc Pedod Prev Dent; 2017; 35(4):367-373. PubMed ID: 28914251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study.
    Subramaniam P; Konde S; Mathew S; Sugnani S
    J Clin Pediatr Dent; 2009; 33(4):311-4. PubMed ID: 19725237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodentine
    El Meligy OAES; Alamoudi NM; Allazzam SM; El-Housseiny AAM
    BMC Oral Health; 2019 Jan; 19(1):3. PubMed ID: 30612569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.